A Prospective Double-Blinded Clinical Trial Using Apatone®B for Care and Treatment of Proven Non-Infected Symptomatic Postoperative Total Joint Arthroplasties
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2017
At a glance
- Drugs Ascorbic acid/menadione (Primary)
- Indications Joint disorders
- Focus Therapeutic Use
- Sponsors IC-MedTech
- 27 Mar 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 27 Mar 2015 Planned primary completion date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 22 May 2014 New trial record